Abstract:Psoriasis is a chronic relapsing/remitting autoimmune disease affecting skin and fingernails. It is associated with many other autoimmune diseases such as rheumatoid arthritis, celiac disease, Crohn's disease, and thyroid diseases. Two important autoimmune thyroid diseases-Hashimoto's thyroiditis (hypothyroidism) and Grave's disease (hyperthyroidism)-affect the body's significant organs such as the brain, muscles, digestive function, and the skin. Although some studies have established the connection between p… Show more
“…Previous research suggests that there are several commonalities in the pathophysiology shared between psoriasis and Graves' disease, such as hormones, genetic factors and oxidative stress. 5 Therefore, when the current patient showed poor responses to a variety of treatments, including conventional therapies, Janus kinase inhibitor inhibitors and biologics, her medical team speculated that this was related to the underlying Graves' disease, so she underwent iodine-131 treatment at same time. Finally, her treatment was switched to the IL-23 inhibitor, guselkumab, which resulted in the resolution of her psoriatic lesions.…”
Section: Discussionmentioning
confidence: 98%
“…2,3 Autoimmune thyroid disease is considered to be closely related to psoriasis, because free thyroxine is increased significantly in psoriatic patients and patients with thyroiditis have more extended disease periods; 4 and in severe psoriasis, there are increased levels of thyroid-stimulating hormone (TSH). 5 Previous studies have demonstrated a link between psoriasis and thyroid illness as well as the involvement of type 1 helper T (Th1) cell cytokines in the pathogenesis of both psoriasis and Graves' disease, which is the most common cause of hyperthyroidism in iodine-replete areas. 5 A previous study indicated that methimazole, the first-line treatment for hyperthyroidism, could alleviate psoriasis through a variety of pathways by lowering the psoriasis area and severity index (PASI) scores of the patients after 6-8 weeks of treatment.…”
Section: Introductionmentioning
confidence: 99%
“… 5 Previous studies have demonstrated a link between psoriasis and thyroid illness as well as the involvement of type 1 helper T (Th1) cell cytokines in the pathogenesis of both psoriasis and Graves’ disease, which is the most common cause of hyperthyroidism in iodine-replete areas. 5 A previous study indicated that methimazole, the first-line treatment for hyperthyroidism, could alleviate psoriasis through a variety of pathways by lowering the psoriasis area and severity index (PASI) scores of the patients after 6–8 weeks of treatment. 6 These studies provide some evidence that thyroid illness exacerbates the severity of psoriasis.…”
Psoriasis is a chronic inflammatory skin disease. It is associated with many autoimmune diseases such as rheumatoid arthritis, Crohn’s disease and thyroid diseases. Graves’ disease (GD) is a common organ-specific autoimmune disease characterized by diffuse goitre and thyrotoxicosis. Management of psoriasis patients with GD is challenging. This current report presents the case of a 34-year-old female patient with refractory psoriasis with GD who was hospitalized for drug eruption and then experienced new-onset erythema and scaling following treatment with adalimumab and secukinumab. Despite the sequential move to phototherapy, tofacitinib and ustekinumab, the erythema and scaling continued unabated and exacerbated. Finally, switching to guselkumab resulted in the psoriasis lesions significantly improving. These findings suggest that guselkumab might be an effective treatment option for refractory psoriasis combined with GD.
“…Previous research suggests that there are several commonalities in the pathophysiology shared between psoriasis and Graves' disease, such as hormones, genetic factors and oxidative stress. 5 Therefore, when the current patient showed poor responses to a variety of treatments, including conventional therapies, Janus kinase inhibitor inhibitors and biologics, her medical team speculated that this was related to the underlying Graves' disease, so she underwent iodine-131 treatment at same time. Finally, her treatment was switched to the IL-23 inhibitor, guselkumab, which resulted in the resolution of her psoriatic lesions.…”
Section: Discussionmentioning
confidence: 98%
“…2,3 Autoimmune thyroid disease is considered to be closely related to psoriasis, because free thyroxine is increased significantly in psoriatic patients and patients with thyroiditis have more extended disease periods; 4 and in severe psoriasis, there are increased levels of thyroid-stimulating hormone (TSH). 5 Previous studies have demonstrated a link between psoriasis and thyroid illness as well as the involvement of type 1 helper T (Th1) cell cytokines in the pathogenesis of both psoriasis and Graves' disease, which is the most common cause of hyperthyroidism in iodine-replete areas. 5 A previous study indicated that methimazole, the first-line treatment for hyperthyroidism, could alleviate psoriasis through a variety of pathways by lowering the psoriasis area and severity index (PASI) scores of the patients after 6-8 weeks of treatment.…”
Section: Introductionmentioning
confidence: 99%
“… 5 Previous studies have demonstrated a link between psoriasis and thyroid illness as well as the involvement of type 1 helper T (Th1) cell cytokines in the pathogenesis of both psoriasis and Graves’ disease, which is the most common cause of hyperthyroidism in iodine-replete areas. 5 A previous study indicated that methimazole, the first-line treatment for hyperthyroidism, could alleviate psoriasis through a variety of pathways by lowering the psoriasis area and severity index (PASI) scores of the patients after 6–8 weeks of treatment. 6 These studies provide some evidence that thyroid illness exacerbates the severity of psoriasis.…”
Psoriasis is a chronic inflammatory skin disease. It is associated with many autoimmune diseases such as rheumatoid arthritis, Crohn’s disease and thyroid diseases. Graves’ disease (GD) is a common organ-specific autoimmune disease characterized by diffuse goitre and thyrotoxicosis. Management of psoriasis patients with GD is challenging. This current report presents the case of a 34-year-old female patient with refractory psoriasis with GD who was hospitalized for drug eruption and then experienced new-onset erythema and scaling following treatment with adalimumab and secukinumab. Despite the sequential move to phototherapy, tofacitinib and ustekinumab, the erythema and scaling continued unabated and exacerbated. Finally, switching to guselkumab resulted in the psoriasis lesions significantly improving. These findings suggest that guselkumab might be an effective treatment option for refractory psoriasis combined with GD.
“…Genetinis polinkis yra reikšmingas psoriazės patogenezėje, tačiau aplinkos veiksniai gali suaktyvinti ligą. Psoriazė yra susijusi su įvairiomis ligomis, įskaitant metabolinį sindromą, cukrinį diabetą, širdies ir kraujagyslių ligas, kitas uždegimines autoimunines ligas, pvz., reumatoidinį artritą, celiakiją, Krono ligą [9]. Daugelis perspektyvinių ir retrospektyvių tyrimų esant skirtingam tiriamųjų skaičiui parodė reikšmingą teigiamą psoriazės ir Hašimoto tiroidito ryšį, kurį patvirtintų: klinikiniai ypatumai (pasireiškimas odoje): pacientams, sergantiems Hašimoto tiroiditu ir kitomis skydliaukės ligomis, dažnai pastebima daugybė odos apraiškų.…”
unclassified
“…Daugelis perspektyvinių ir retrospektyvių tyrimų esant skirtingam tiriamųjų skaičiui parodė reikšmingą teigiamą psoriazės ir Hašimoto tiroidito ryšį, kurį patvirtintų: klinikiniai ypatumai (pasireiškimas odoje): pacientams, sergantiems Hašimoto tiroiditu ir kitomis skydliaukės ligomis, dažnai pastebima daugybė odos apraiškų. Pavyzdžiui, pacientams, sergantiems psoriaze ir itin sunkiu hipotiroidizmu, buvo pastebėtas reikšmingas odos pažeidimų pagerėjimas normalizavus tiroksino kiekį organizme [9];• keletas patofiziologinių mechanizmų, bendrų psoriazei ir skydliaukės ligoms. Vieną iš svarbiausių vaidmenų atlieka hormonai: skydliaukės hormonai ir jų receptoriai, esantys odoje, yra būtini skatinti odos proliferaciją, veikdami kaip endogeniniai odos uždegimo inhibitoriai bei didindami epidermio augimo veiksnio kiekį (skatina keratinocitų proliferaciją ir diferenciaciją).…”
Hašimoto tiroiditas – tai lėtinis autoimuninis skydliaukės uždegimas, atsirandantis dėl imuninių procesų, kuriuos sukelia tokie autoantikūnai kaip antikūnai prieš skydliaukės peroksidazę, antikūnai prieš tiroglobuliną ir antikūnai prieš TSH receptorius. Ligos paplitimui įtakos turi daugelis veiksnių, tačiau svarbiausi iš jų yra lytis, amžius ir socioekonominis lygmuo. Nustatyta, kad apie 20 proc. atvejų autoimuninis tiroiditas yra susijęs su kitais autoimuniniais sutrikimais. Vienas jų – psoriazė. Psoriazė yra lėtinė uždegiminė odos liga, kuriai būdingos eriteminės plokštelės, padengtos sidabriniu žvynu. Šių dviejų ligų galimą ryšį rodo klinikiniai ypatumai, tam tikri patofiziologiniai mechanizmai, diagnostikos ypatumai ir vaistų poveikis. Šio tyrimo tikslas − išanalizuoti ir apžvelgti mokslinius literatūros straipsnius, aprašančius autoimuninį tiroiditą, jo paplitimą, žymenis ir ryšį su psoriaze.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.